EU/US Trade - Vital Signs

Sign in Subscribe

EU/US Trade

A collection of 7 posts

Inside EU Health: ESF+ for abortion access; pharma reforms could reduce costs by 20-25%; pharma 29% of exports to US; ECCE receives lukewarm welcome

Inside EU Health

Inside EU Health: ESF+ for abortion access; pharma reforms could reduce costs by 20-25%; pharma 29% of exports to US; ECCE receives lukewarm welcome

Commission open ESF+ pathway for abortion access; EU’s Health Package is Europe’s answer to Trump’s drug pricing policy, says Várhelyi; medical and pharmaceutical products were the leading export category to US in 2025; ECCE idea receives lukewarm welcome

Inside EU Health: Tariff chaos, court setback on Urban Wastewater for pharma; EMA starts its search for a new Executive Director

Inside EU Health

Inside EU Health: Tariff chaos, court setback on Urban Wastewater for pharma; EMA starts its search for a new Executive Director

‘Tariff chaos’ but pharmaceuticals may stay outside the fray; industry groups continue to fight Wastewater Treatment Directive despite court setback; EMA starts its search for a new Executive Director

‘Tariff chaos’ but pharmaceuticals may stay outside the fray

‘Tariff chaos’ but pharmaceuticals may stay outside the fray

US tariff reset sparks trade uncertainty, following court ruling might spare pharmaceuticals - for the time being

US tariffs and MFN pricing threaten pharma investment and access in Europe

US tariffs and MFN pricing threaten pharma investment and access in Europe

Rising uncertainty driven by US tariffs and proposed “most-favoured nation” pricing is prompting pharmaceutical companies to delay investment and product launches in Europe

Merck the latest to up US investment in the face of Trump threats

Merck the latest to up US investment in the face of Trump threats

Another European company bows to Trumps threats by increasing investment commitments in US

EU calms fears as Trump tweet raises alarm on tariffs – but drug-pricing pressure remains

EU calms fears as Trump tweet raises alarm on tariffs – but drug-pricing pressure remains

Concern over a tweet threatening to impose 100% tariffs on pharma companies was quickly quelled, but concerns on pricing remains

Pharma seeks strategic dialogue to secure its future

Pharma seeks strategic dialogue to secure its future

Welcome to the first Vital Signs post! EU/US Trade: While many of us will have used the summer break to recharge our batteries, spare a thought for Maroš Šefčovič, EU Commissioner for Trade and Economic Security, who was locked in negotiations with the United States throughout July and August,